InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Phone+1-248-2911210
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees234
OptionableNot Optionable
InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions
What is InfuSystem's stock symbol?
InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."
How will InfuSystem's stock buyback program work?
InfuSystem announced that its Board of Directors has initiated a share buyback program on Tuesday, March 13th 2018, which permits the company to repurchase 1,000,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company's board of directors believes its stock is undervalued.
How were InfuSystem's earnings last quarter?
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its quarterly earnings results on Tuesday, November, 13th. The medical instruments supplier reported ($0.03) EPS for the quarter. The medical instruments supplier had revenue of $16.68 million for the quarter. View InfuSystem's Earnings History.
When is InfuSystem's next earnings date?
Has InfuSystem been receiving favorable news coverage?
News articles about INFU stock have trended positive on Monday, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InfuSystem earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future.
Who are some of InfuSystem's key competitors?
Some companies that are related to InfuSystem include Advanced Medical Solutions (AMS), Akers Biosciences (AKR), Ansell (ANN), ANSELL LTD/S (ANSLY), Bovie Medical (BVX), Bovie Medical (BVX), Clover (CLV), CONVATEC GRP PL/ADR (CNVVY), CRH Medical (CRHM), CRH Medical (CRH), Daxor (DXR), Enerplus (ERF), Essilor International Cmgn Gnl D Optq (EI), Gerresheimer (GXI) and Iris BioTechnologies (IRSB).
Who are InfuSystem's key executives?
InfuSystem's management team includes the folowing people:
- Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
- Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
- Mr. Tom Ruiz, Sr. VP of Sales & Marketing
- Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
- Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives
How do I buy shares of InfuSystem?
Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is InfuSystem's stock price today?
One share of INFU stock can currently be purchased for approximately $3.61.
What is InfuSystem's official website?
How can I contact InfuSystem?
InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.
MarketBeat Community Rating for InfuSystem (NYSEAMERICAN INFU)
MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe INFU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INFU will underperform the S&P 500 over the long term. You may vote once every thirty days.
